Literature DB >> 1707877

Delineation via site-directed mutagenesis of the carboxyl-terminal region of human choriogonadotropin beta required for subunit assembly and biological activity.

F Chen1, D Puett.   

Abstract

The choriogonadotropin beta subunit is unique in the human glycoprotein hormone family in containing a carboxyl-terminal extension, with four sites of O-glycosylation, that is not present in the other beta subunits. We have used site-directed mutagenesis to define boundaries on the extent to which truncations can be made at the COOH terminus without abolishing subunit assembly and biological activity. Two COOH-terminal deletion mutant chains of human choriogonadotropin beta, des(93-145) and des(101-145), were prepared and expressed in Chinese hamster ovary cells containing a stably integrated gene for bovine alpha. The heterologous gonadotropin, bovine alpha-human choriogonadotropin des(101-145) beta, formed a heterodimer and, when assayed with transformed murine Leydig cells in vitro, competed with the binding of standard human choriogonadotropin and stimulated both cAMP and progesterone production, albeit with a reduced potency relative to bovine alpha-human choriogonadotropin beta wild type. In contrast, human choriogonadotropin des(93-145) beta, expressed under identical conditions in the presence of bovine alpha, failed to form heterodimer and thus exhibited no competitive binding and was without effect on cAMP and progesterone levels. Consequently, removal of the putative determinant loop region of the beta subunit (residues 93-100), which is believed to be important in determining receptor specificity, abolishes association with alpha. Hence, in addition to its possible role as a receptor determinant, this region of the molecule appears to be critical for proper folding or subunit interaction. The truncated form of human choriogonadotropin beta lacking residues 101-145 is the shortest form of the subunit yet described that retains biological activity. Moreover, these results demonstrate that the proposed disulfide between Cys-26 and Cys-110 is not required for subunit assembly or for receptor binding and subsequent intracellular signaling.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1707877

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

Review 1.  Minireview: Insights Into the Structural and Molecular Consequences of the TSH-β Mutation C105Vfs114X.

Authors:  Gunnar Kleinau; Laura Kalveram; Josef Köhrle; Mariusz Szkudlinski; Lutz Schomburg; Heike Biebermann; Annette Grüters-Kieslich
Journal:  Mol Endocrinol       Date:  2016-07-07

2.  On the role of the invariant glutamine at position 54 in the human choriogonadotropin beta subunit.

Authors:  J Huang; D Puett
Journal:  Mol Cell Biochem       Date:  1994-07-27       Impact factor: 3.396

3.  Characterization of tethered equine chorionic gonadotropin and its deglycosylated mutants by ovulation stimulation in mice.

Authors:  Kwan-Sik Min; Jong-Ju Park; Munkhzaya Byambaragchaa; Myung-Hwa Kang
Journal:  BMC Biotechnol       Date:  2019-08-13       Impact factor: 2.563

4.  The Pathogenic TSH β-subunit Variant C105Vfs114X Causes a Modified Signaling Profile at TSHR.

Authors:  Laura Kalveram; Gunnar Kleinau; Kamila Szymańska; Patrick Scheerer; Adolfo Rivero-Müller; Annette Grüters-Kieslich; Heike Biebermann
Journal:  Int J Mol Sci       Date:  2019-11-07       Impact factor: 5.923

Review 5.  Comparative structure analyses of cystine knot-containing molecules with eight aminoacyl ring including glycoprotein hormones (GPH) alpha and beta subunits and GPH-related A2 (GPA2) and B5 (GPB5) molecules.

Authors:  Eva Alvarez; Claire Cahoreau; Yves Combarnous
Journal:  Reprod Biol Endocrinol       Date:  2009-08-31       Impact factor: 5.211

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.